Eastman Chemical (EMN) Asset Writedowns and Impairment (2009 - 2025)

Eastman Chemical has reported Asset Writedowns and Impairment for 11 years, with the latest figure at $33.0 million in Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at $33.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $38.0 million (up 660.0% YoY), and the FY2025 annual result was $33.0 million, up 560.0% from the prior year.
• Asset Writedowns and Impairment grew to $33.0 million in Q4 2025, from $5.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $33.0 million in Q4 2025 and troughed at $5.0 million in Q2 2021.
• A 3-year average of $13.5 million and a median of $8.0 million in 2021 frame the typical range for Asset Writedowns and Impairment.
• The largest YoY upside for Asset Writedowns and Impairment was 1000.0% in 2021 against a maximum downside of 96.32% in 2021.
• A 3-year view of Asset Writedowns and Impairment shows it stood at $11.0 million in 2021, then plunged by 54.55% to $5.0 million in 2024, then surged by 560.0% to $33.0 million in 2025.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $33.0 million in Q4 2025, $5.0 million in Q3 2024, and $11.0 million in Q4 2021.